Hansen Medical Inc (HNSN.OQ) Quote| Reuters.com
Edition:
United States

Hansen Medical Inc (HNSN.OQ)

HNSN.OQ on NASDAQ Stock Exchange Global Market

3.98USD
29 Jun 2016
Change (% chg)

$0.01 (+0.25%)
Prev Close
$3.97
Open
$3.99
Day's High
$3.99
Day's Low
$3.97
Volume
1,642
Avg. Vol
15,583
52-wk High
$10.80
52-wk Low
$1.29

HNSN.OQ

Chart for HNSN.OQ

About

Hansen Medical, Inc. is engaged in the development and marketing of medical devices. The Company develops, manufactures and sells a range of medical robotics designed for positioning, manipulation and stable control of catheters and catheter-based technologies. Its products include Sensei Robotic Catheter System (Sensei system),... (more)

Overall

Beta: 0.38
Market Cap(Mil.): $75.39
Shares Outstanding(Mil.): 18.99
Dividend: --
Yield (%): --

Financials

  HNSN.OQ Industry Sector
P/E (TTM): -- 31.02 34.69
EPS (TTM): -31.62 -- --
ROI: -203.33 8.50 14.13
ROE: -- 12.81 15.35

BRIEF-Westwood SPV LLC reports 9.58 pct stake in Hansen Medical

* Westwood SPV LLC reports 9.58 pct stake in Hansen Medical inc as of April 8 - Sec filing Source text for Eikon: [ID: http://1.usa.gov/1SZUOnL Further company coverage: (Bengaluru Newsroom; +1 646 223 8780)

Apr 25 2016

BRIEF-Hansen Medical Inc says Hansen may be required to pay parent termination fee of $3.325 mln, if Co were to terminate merger agreement

* Hansen may be required to pay parent a termination fee of $3.325 million, if hansen were to terminate merger agreement Source text [http://1.usa.gov/1SbJOI3] Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Apr 20 2016

BRIEF-Hansen Medical to restate financial statements for three, six months ended June 30, 2015

* On March 25, 2016, audit committee of board determined co will be required to restate financial statements for three,six months ended June 30, 2015

Mar 31 2016

BRIEF-Hansen medical files for non-timely 10-k - sec filing

* Files for non-timely 10-k - sec filing Source text : http://1.usa.gov/22k0nEX Further company coverage:

Mar 15 2016

Chr. Hansen to buy U.S.-based NPC for $185 million

COPENHAGEN Danish food ingredients maker Chr. Hansen said on Wednesday it has agreed to buy Nutrition Physiology Company (NPC) for $185 mln and will cancel a planned share buy-back program and interim dividends in the financial year 2015/16.

Jan 13 2016

Chr. Hansen to buy U.S.-based NPC for $185 mln

COPENHAGEN, Jan 13 Danish food ingredients maker Chr. Hansen said on Wednesday it has agreed to buy Nutrition Physiology Company (NPC) for $185 mln and will cancel a planned share buy-back programme and interim dividends in the financial year 2015/16.

Jan 13 2016

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : Stock Traders Daily
$20.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$104.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.